ArticleMolecular medicine reports2017

A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.

Aryo D Pamungkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.